Recap: Arcus Biosciences Q4 Earnings

Comments
Loading...

Arcus Biosciences RCUS reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:10 PM.

Here's what investors need to know about the announcement.

Earnings

Arcus Biosciences beat estimated earnings by 601.35%, reporting an EPS of $3.71 versus an estimate of $-0.74.

Revenue was up $345.01 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 11.97% increase in the share price the next day.

Here's a look at Arcus Biosciences's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -1.08 -0.88 -0.84 -0.75
EPS Actual -1.11 -1.09 -1.08 -0.82
Revenue Estimate 9.40M 13.05M 13.34M 7.93M
Revenue Actual 9.46M 9.46M 9.46M 9.49M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

RCUS Logo
RCUSArcus Biosciences Inc
$9.54-1.65%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum9.27
Growth87.29
Quality-
Value64.07
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: